Study of gildeuretinol in patients with Stargardt disease
Latest Information Update: 14 Feb 2025
At a glance
- Drugs Gildeuretinol (Primary)
- Indications Stargardt disease
- Focus Therapeutic Use
- Acronyms TEASE-2
Most Recent Events
- 11 Feb 2025 According to the Alkeus Pharmaceuticals Media Release, safety and efficacy results from TEASE program will be presented at the 48th Annual Meeting of the Macula Society being held February 12-15 in Charlotte Harbor, Fla.
- 05 Dec 2024 According to the Alkeus Pharmaceuticals Media Release, topline data from this study expected in 2025.
- 09 Jun 2023 New trial record